Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $17.3 million.

  • Neurogene's Non-Current Assets fell 1543.5% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.4 million, marking a year-over-year decrease of 1209.26%. This contributed to the annual value of $19.8 million for FY2024, which is 1087.96% down from last year.
  • Neurogene's Non-Current Assets amounted to $17.3 million in Q3 2025, which was down 1543.5% from $18.3 million recorded in Q2 2025.
  • Neurogene's Non-Current Assets' 5-year high stood at $22.2 million during Q4 2023, with a 5-year trough of $9.7 million in Q3 2023.
  • In the last 3 years, Neurogene's Non-Current Assets had a median value of $18.9 million in 2025 and averaged $17.4 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 11121.43% in 2024, then crashed by 1543.5% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Non-Current Assets stood at $22.2 million in 2023, then fell by 10.88% to $19.8 million in 2024, then decreased by 12.59% to $17.3 million in 2025.
  • Its Non-Current Assets stands at $17.3 million for Q3 2025, versus $18.3 million for Q2 2025 and $18.9 million for Q1 2025.